Genertec Universal Medical Group Co., Ltd. (2666) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Qifu Technology. Inc.

Far East Horizon Ltd.

BOC Aviation Ltd.

Genertec Universal Medical Group Co., Ltd.

SY Holdings Group Ltd.

Sun Hung Kai & Co. Ltd.

Shandong Hi-Speed Holdings Group Ltd.

Allied Group Ltd.

Horizon Construction Development Ltd.

CITIC Ltd.

Hao Tian International Construction Investment Group Ltd.

Why is Genertec Universal Medical Group Co., Ltd. ?

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 13.52%

Positive results in Jun 25

OPERATING CASH FLOW(Y) Highest at HKD 8,816.28 MM
INTEREST COVERAGE RATIO(Q) Highest at 312.22
DEBT-EQUITY RATIO (HY) Lowest at 272.55 %

With ROE of 23.38%, it has a Attractive valuation with a 0.59 Price to Book Value

Over the past year, while the stock has generated a return of 11.32%, its profits have risen by 2.5% ; the PEG ratio of the company is 1

Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks

Market Beating performance in long term as well as near term

Along with generating 11.32% returns in the last 1 year, the stock has outperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Genertec Universal Medical Group Co., Ltd. should be less than 10%
Overall Portfolio exposure to Finance should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Finance)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Genertec Universal Medical Group Co., Ltd. for you?

Low Risk, High Return

Absolute

Risk Adjusted

Volatility

Genertec Universal Medical Group Co., Ltd.

11.32%

1.12

25.90%

Hang Seng Hong Kong

8.25%

0.41

19.93%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

13.59%

EBIT Growth (5y)

3.64%

EBIT to Interest (avg)

2.37

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

22.52%

Dividend Payout Ratio

30.05%

Pledged Shares

Institutional Holding

ROCE (avg)

43.68%

ROE (avg)

13.52%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.59

EV to EBIT

1.86

EV to EBITDA

1.60

EV to Capital Employed

0.51

EV to Sales

0.50

PEG Ratio

1.03

Dividend Yield

1.65%

ROCE (Latest)

27.20%

ROE (Latest)

23.38%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Bullish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company

OPERATING CASH FLOW(Y)

Highest at HKD 8,816.28 MM

INTEREST COVERAGE RATIO(Q)

Highest at 312.22

DEBT-EQUITY RATIO (HY)

Lowest at 272.55 %

DEBTORS TURNOVER RATIO(HY)

Highest at 0.21 times

NET SALES(Q)

Highest at HKD 8,222.78 MM

PRE-TAX PROFIT(Q)

Highest at HKD 1,871.41 MM

NET PROFIT(Q)

Highest at HKD 1,319.2 MM

EPS(Q)

Highest at HKD 0.66

-3What is not working for the Company

ROCE(HY)

Lowest at 12.21%

RAW MATERIAL COST(Y)

Grown by 12.05% (YoY

Here's what is working for Genertec Universal Medical Group Co., Ltd.

Operating Cash Flow

Highest at HKD 8,816.28 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (HKD MM)

Interest Coverage Ratio

Highest at 312.22

in the last five periods

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales

Highest at HKD 8,222.78 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (HKD MM)

Pre-Tax Profit

Highest at HKD 1,871.41 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Net Profit

Highest at HKD 1,319.2 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (HKD MM)

EPS

Highest at HKD 0.66

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (HKD)

Debt-Equity Ratio

Lowest at 272.55 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio

Highest at 0.21 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Depreciation

Highest at HKD 368.06 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Here's what is not working for Genertec Universal Medical Group Co., Ltd.

Raw Material Cost

Grown by 12.05% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales